EGRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 28.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $295,836.03

Eagle Pharmaceuticals Insider Trading History Chart

Eagle Pharmaceuticals Share Price & Price History

^$5.72

▼ -0.02 (-0.35%)

As of 07/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Kiss of death from Joe Biden

From Porter & Company | Ad

I did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but they do not care.

I have uncovered a bombshell that changes everything… and threatens everything.

Eagle Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/1/2023	Scott Tarriff	CEO	Sell	10,925	$13.82	$150,983.50	556,141
10/2/2023	Scott Tarriff	CEO	Sell	9,511	$15.23	$144,852.53	577,800
5/15/2023	Scott Tarriff	CEO	Sell	15,000	$21.07	$316,050.00	1,594,934
5/11/2023	Scott Tarriff	CEO	Sell	15,000	$20.71	$310,650.00	1,624,934
9/6/2022	Richard A Edlin	Director	Sell	6,800	$30.99	$210,732.00	22,600

The next companies to potentially benefit thanks to Nvidia are …

From Weiss Ratings | Ad

Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.

Click here to learn more.

SEC Filings (Institutional Ownership Changes) for Eagle Pharmaceuticals (NASDAQ:EGRX)

85.36% of Eagle Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Eagle Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/16/2024	Jacobs Levy Equity Management Inc.	10,215	$54K	0.0%	-34.4%	0.079%
5/16/2024	Kennedy Capital Management LLC	55,748	$0.29M	0.0%	-24.5%	0.429%
5/15/2024	Price T Rowe Associates Inc. MD	15,748	$83K	0.0%	N/A	0.121%
5/10/2024	Acadian Asset Management LLC	52,446	$0.27M	0.0%	-81.8%	0.404%
5/10/2024	Vanguard Group Inc.	640,754	$3.36M	0.0%	+0.4%	4.934%
5/8/2024	Headlands Technologies LLC	6,641	$35K	0.0%	+75.7%	0.051%
5/6/2024	LSV Asset Management	334,158	$1.75M	0.0%	-14.7%	2.572%
5/1/2024	BNP Paribas Financial Markets	37,385	$0.20M	0.0%	-57.8%	0.288%
4/24/2024	Assenagon Asset Management S.A.	185,337	$0.97M	0.0%	-14.9%	1.427%
4/15/2024	DGS Capital Management LLC	61,944	$0.33M	0.1%	+442.5%	0.477%
4/5/2024	Los Angeles Capital Management LLC	191,732	$1.01M	0.0%	+110.1%	1.476%
2/13/2024	Aristides Capital LLC	16,451	$86K	0.0%	N/A	0.127%
2/13/2024	Tower Research Capital LLC TRC	6,841	$36K	0.0%	+623.9%	0.053%
2/9/2024	Oxford Asset Management LLP	19,358	$0.10M	0.2%	N/A	0.149%
2/9/2024	Brandes Investment Partners LP	745,080	$3.90M	0.1%	-34.3%	5.736%
2/9/2024	Trexquant Investment LP	126,282	$0.66M	0.0%	+88.0%	0.972%
2/7/2024	Jump Financial LLC	38,900	$0.20M	0.0%	+172.0%	0.299%
2/7/2024	BNP Paribas Financial Markets	88,685	$0.46M	0.0%	+378.7%	0.683%
2/6/2024	LSV Asset Management	391,758	$2.05M	0.0%	-4.2%	3.016%
2/6/2024	Los Angeles Capital Management LLC	91,262	$0.48M	0.0%	+68.1%	0.703%
1/30/2024	DGS Capital Management LLC	11,419	$60K	0.0%	N/A	0.088%
1/19/2024	Denali Advisors LLC	26,600	$0.14M	0.0%	-17.6%	0.205%
11/22/2023	Connors Investor Services Inc.	12,566	$0.20M	0.0%	+24.8%	0.097%
11/15/2023	Kennedy Capital Management LLC	36,486	$0.58M	0.0%	N/A	0.281%
11/15/2023	Adage Capital Partners GP L.L.C.	500,000	$7.89M	0.0%	+25.0%	3.849%
11/15/2023	AQR Capital Management LLC	282,958	$4.46M	0.0%	-23.1%	2.178%
11/14/2023	Trexquant Investment LP	67,187	$1.06M	0.0%	+26.1%	0.517%
11/13/2023	Brandes Investment Partners LP	1,134,363	$17.89M	0.3%	+34.9%	8.733%
11/13/2023	Acadian Asset Management LLC	236,902	$3.73M	0.0%	+5.5%	1.824%
11/13/2023	ClariVest Asset Management LLC	22,262	$0.35M	0.0%	-28.9%	0.171%
11/9/2023	Scout Investments Inc.	131,192	$2M	0.0%	-2.8%	1.010%
11/9/2023	Blair William & Co. IL	22,450	$0.35M	0.0%	-7.5%	0.173%
11/9/2023	Headlands Technologies LLC	2,326	$37K	0.0%	+263.4%	0.018%
11/8/2023	Massachusetts Financial Services Co. MA	31,356	$0.49M	0.0%	-3.7%	0.241%
11/7/2023	Smith Graham & Co. Investment Advisors LP	273,099	$4.31M	0.5%	+1.4%	2.103%
11/7/2023	Quantbot Technologies LP	2,400	$38K	0.0%	-52.9%	0.018%
11/7/2023	New York State Common Retirement Fund	6,414	$0.10M	0.0%	-58.1%	0.049%
11/7/2023	Barclays PLC	10,622	$0.17M	0.0%	-57.8%	0.082%
11/7/2023	Jump Financial LLC	14,300	$0.23M	0.0%	-7.1%	0.110%
11/6/2023	Assenagon Asset Management S.A.	217,668	$3.43M	0.0%	+66.5%	1.676%
11/6/2023	Los Angeles Capital Management LLC	54,280	$0.86M	0.0%	-22.1%	0.418%
10/27/2023	Allspring Global Investments Holdings LLC	191,635	$3.02M	0.0%	+11.8%	1.475%
10/26/2023	Strs Ohio	9,200	$0.15M	0.0%	N/A	0.071%
10/24/2023	Bank of New York Mellon Corp	63,229	$1M	0.0%	-1.6%	0.487%
10/20/2023	Denali Advisors LLC	32,300	$0.51M	0.2%	+52.4%	0.249%
10/18/2023	Exchange Traded Concepts LLC	23,209	$0.37M	0.0%	N/A	0.179%
8/24/2023	Alberta Investment Management Corp	17,606	$0.34M	0.0%	-10.2%	0.136%
8/15/2023	Capital Impact Advisors LLC	25,136	$0.49M	0.5%	+84.7%	0.194%
8/14/2023	WINTON GROUP Ltd	24,234	$0.47M	0.0%	+3.8%	0.187%
8/11/2023	Panagora Asset Management Inc.	12,282	$0.24M	0.0%	N/A	0.095%
8/11/2023	Trexquant Investment LP	53,277	$1.04M	0.0%	+251.5%	0.410%
8/9/2023	BNP Paribas Arbitrage SNC	43,019	$0.84M	0.0%	+121.2%	0.329%
8/7/2023	Acadian Asset Management LLC	224,576	$4.36M	0.0%	+4.2%	1.716%
8/7/2023	Royce & Associates LP	59,214	$1.15M	0.0%	+24.3%	0.452%
8/4/2023	American International Group Inc.	4,980	$97K	0.0%	-11.0%	0.038%
8/3/2023	Los Angeles Capital Management LLC	69,684	$1.36M	0.0%	-6.6%	0.532%
8/2/2023	Bank of Montreal Can	48,305	$0.97M	0.0%	N/A	0.369%
8/2/2023	LSV Asset Management	408,758	$7.95M	0.0%	+67.7%	3.123%
7/31/2023	Smith Graham & Co. Investment Advisors LP	269,451	$5.24M	0.6%	+13.7%	2.058%
7/27/2023	Victory Capital Management Inc.	28,880	$0.56M	0.0%	+55.5%	0.221%
7/25/2023	Ziegler Capital Management LLC	17,914	$0.35M	0.0%	+21.1%	0.137%
7/25/2023	Assenagon Asset Management S.A.	130,751	$2.54M	0.0%	-25.1%	0.999%
7/24/2023	Allspring Global Investments Holdings LLC	171,431	$3.33M	0.0%	-22.9%	1.310%
7/24/2023	SummerHaven Investment Management LLC	13,851	$0.27M	0.2%	-23.8%	0.106%
7/18/2023	Denali Advisors LLC	21,200	$0.41M	0.1%	+960.0%	0.162%
7/18/2023	Allspring Global Investments Holdings LLC	171,431	$3.33M	0.0%	-22.9%	1.310%
5/23/2023	Capital Impact Advisors LLC	13,607	$0.39M	0.5%	+7.1%	0.104%
5/23/2023	Royce & Associates LP	47,632	$1.35M	0.0%	+35.3%	0.364%
5/12/2023	WINTON GROUP Ltd	23,357	$0.66M	0.0%	+18.1%	0.178%
5/11/2023	Acadian Asset Management LLC	215,431	$6.11M	0.0%	-7.0%	1.646%
5/10/2023	Brandes Investment Partners LP	545,050	$15.46M	0.3%	+31.0%	4.164%
5/10/2023	South Dakota Investment Council	27,562	$0.78M	0.0%	+3.3%	0.211%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	9,309	$0.26M	0.0%	N/A	0.071%
5/9/2023	Principal Financial Group Inc.	68,620	$1.95M	0.0%	-3.2%	0.524%
5/9/2023	Smith Graham & Co. Investment Advisors LP	236,883	$6.72M	0.8%	+2.4%	1.810%
5/9/2023	Y Intercept Hong Kong Ltd	8,756	$0.25M	0.0%	-13.4%	0.067%
5/8/2023	Federated Hermes Inc.	67,079	$1.90M	0.0%	-4.3%	0.512%
5/8/2023	Zurcher Kantonalbank Zurich Cantonalbank	2,055	$58K	0.0%	-18.6%	0.016%
5/4/2023	Royce & Associates LP	47,632	$1.35M	0.0%	+35.3%	0.364%
5/4/2023	Los Angeles Capital Management LLC	74,615	$2.12M	0.0%	+76.5%	0.570%
5/3/2023	Jump Financial LLC	25,451	$0.72M	0.0%	+250.4%	0.195%
5/2/2023	LSV Asset Management	243,736	$6.92M	0.0%	+61.0%	1.863%
5/2/2023	Victory Capital Management Inc.	18,572	$0.53M	0.0%	-35.1%	0.142%
5/1/2023	Texas Permanent School Fund Corp	9,338	$0.27M	0.0%	+35.0%	0.071%
4/28/2023	Signaturefd LLC	1,561	$44K	0.0%	+197.3%	0.012%
4/28/2023	SG Americas Securities LLC	7,971	$0.23M	0.0%	N/A	0.061%
4/27/2023	New York State Teachers Retirement System	18,017	$0.51M	0.0%	-2.2%	0.138%
4/27/2023	Simplicity Solutions LLC	10,164	$0.29M	0.0%	N/A	0.078%
4/26/2023	James Investment Research Inc.	1,704	$48K	0.0%	N/A	0.013%
4/18/2023	Assenagon Asset Management S.A.	174,660	$4.96M	0.0%	+55.6%	1.335%
4/13/2023	Allspring Global Investments Holdings LLC	222,430	$6.31M	0.0%	+47.7%	1.701%
4/13/2023	SummerHaven Investment Management LLC	18,178	$0.52M	0.3%	+3.2%	0.139%
2/14/2023	Campbell & CO Investment Adviser LLC	22,547	$0.66M	0.2%	-52.8%	0.173%
2/10/2023	New York Life Investment Management LLC	11,460	$0.34M	0.0%	+12.7%	0.088%
2/10/2023	HRT Financial LP	61,059	$1.78M	0.0%	N/A	0.469%
2/10/2023	Blair William & Co. IL	39,172	$1.15M	0.0%	-7.5%	0.301%
2/9/2023	Bank of Nova Scotia	85,293	$2.49M	0.0%	N/A	0.655%
2/9/2023	First Trust Advisors LP	26,259	$0.77M	0.0%	-6.7%	0.202%
2/9/2023	Victory Capital Management Inc.	31,337	$1.06M	0.0%	+25.1%	0.241%
2/9/2023	Principal Financial Group Inc.	70,905	$2.07M	0.0%	-0.5%	0.545%

Data available starting January 2016

Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium to treat organophosphate exposure; PEMFEXY, a ready-to-use/dilute liquid form of pemetrexed for non-small cell lung cancer and mesothelioma; EA-114 (fulvestrant) for HR+/HER- breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an antitoxin agent for the treatment of severe pneumonia in combination with traditional antibacterial drugs; and AOP Orphan Pharmaceuticals GmbH for the commercial rights of Landiolol, a novel therapeutic product candidate for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat breast cancer (HR+/HER2-) and high-risk metastatic sarcomas. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.

Today's Range

Now: $5.72

$5.64

$5.94

50 Day Range

MA: $4.71

$3.34

$6.07

52 Week Range

Now: $5.72

$3.21

$23.52

Volume

33,656 shs

Average Volume

199,029 shs

Market Capitalization

$74.30 million

P/E Ratio

4.85

Dividend Yield

N/A

Beta

0.51

Who are the company insiders with the largest holdings of Eagle Pharmaceuticals?: Eagle Pharmaceuticals' top insider investors include:
Scott Tarriff (CEO)
Richard A Edlin (Director)
Learn More about top insider investors at Eagle Pharmaceuticals.